BORDERLINE RESECTABLE PANCREATIC CANCER: Need for Standardization and Methods for Optimal Clinical Trial Design

Methodological limitations of prior studies have prevented progress in the treatment of patients with borderline resectable pancreatic adenocarcinoma. Shortcomings have included the absence of staging and treatment standards and pre-existing biases with regard to the use of neoadjuvant therapy and t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Surg Oncol
Autors principals: Katz, Matthew HG, Marsh, Robert, Herman, Joseph M., Shi, Qian, Collison, Eric, Venook, Alan, Kindler, Hedy, Alberts, Steven, Philip, Philip, Lowy, Andrew M., Pisters, Peter, Posner, Mitchell, Berlin, Jordan, Ahmad, Syed A.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5600517/
https://ncbi.nlm.nih.gov/pubmed/23435609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-2886-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars